首页> 外文期刊>Acta Cardiologica >Central aortic pressure in aortic aneurysm and aortic dissection: a novel prognostic marker.
【24h】

Central aortic pressure in aortic aneurysm and aortic dissection: a novel prognostic marker.

机译:主动脉瘤和主动脉夹层中的主动脉中央压:一种新的预后标志物。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Some aortic aneurysm (AA) or aortic dissection (AD) patients can be observed to detect disease progression if optimal blood pressure is achieved. However, in another group of patients, disease progression occurs despite well-controlled blood pressure. The aim of this study was to determine the prognostic value of central aortic pressure in AA and AD. METHODS: Fifty-six newly diagnosed AA or AD patients (37 men, age: 60.3 +/- 12.9 years) who did not need urgent surgery or interventional treatment were enrolled. All patients achieved brachial SBP < or = 120 mm Hg with beta-blocker-based treatment within 1 month. Then, central aortic pressure parameters were noninvasively checked with radial tonometry (SphygmoCor Px Pulse Wave Analysis System, AtCor Medical, Sydney, Australia). All patients were monitored for at least 6 months and for up to 5 years. RESULTS: Thirty-three patients did well without disease progression. However, disease progression was noted despite well-controlled brachial blood pressure in 23 patients. In intergroup comparisons, central aortic systolic pressure (112.7 +/- 3.5 mm Hg vs. 104.3 +/- 7.5 mm Hg) and aortic augmentation index (AI: 33.4 +/- 13.5% vs. 23.4 +/- 8.7%) were significantly high in the disease progression group (P < 0.05). CONCLUSION: In some AA or AD patients, central aortic pressure and AI can be considered as surrogate prognostic markers.
机译:背景:如果达到最佳血压,可以观察到一些主动脉瘤(AA)或主动脉夹层(AD)患者检测疾病进展。然而,在另一组患者中,尽管血压得到良好控制,疾病仍会发生。这项研究的目的是确定AA和AD中主动脉主动脉压力的预后价值。方法:纳入56例新诊断的AA或AD患者(37名男性,年龄:60.3 +/- 12.9岁),他们不需要急诊手术或介入治疗。所有患者均在1个月内通过基于β受体阻滞剂的治疗达到肱SBP <或= 120 mm Hg。然后,通过径向眼压计(SphygmoCor Px脉搏波分析系统,AtCor Medical,澳大利亚悉尼)无创地检查中心主动脉压力参数。监测所有患者至少6个月,最长5年。结果:33例患者病情进展顺利。然而,尽管有23例肱动脉血压得到良好控制,但仍注意到疾病进展。在组间比较中,主动脉中央收缩压(112.7 +/- 3.5 mm Hg vs. 104.3 +/- 7.5 mm Hg)和主动脉扩张指数(AI:33.4 +/- 13.5%vs. 23.4 +/- 8.7%)显着在疾病进展组中较高(P <0.05)。结论:在一些AA或AD患者中,中心主动脉压和AI可被视为替代预后标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号